INmune Bio Inc (NASDAQ:INMB)
| 10.86 Delayed Data As of Dec 08 |  +0.71 / +7.00%Today’s Change | 5.87 Today|||52-Week Range 11.26 | +71.29% Year-to-Date |
Latest INMB News | Press Releases
No recent news for INmune Bio Inc.
Today’s Trading
| Previous close | 10.15 |
| Today’s open | 10.11 |
| Day’s range | 10.11 - 11.00 |
| Volume | 4,054 |
| Average volume (3 months) | 40,592 |
| Market cap | $171.6M |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +19.04% |
| Earnings growth (this year) | -13.60% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +106.63% |
| P/E ratio | NM |
| Price/Sales | 303.90 |
| Price/Book | 2.84 |
Competitors
Data as of 3:59pm ET, 12/08/2023
Financials
| Next reporting date | February 29, 2024 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $374.0K |
| Annual profit (last year) | -$27.3M |
| Net profit margin | -7,299.20% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boca Raton, Florida |
Forecasts
